The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> February 27, 2015

Interview with the President, CEO and Director: BioSig Technologies, Inc. (BSGM)

Cash, Greg
Gregory D. Cash is President, CEO and Director of BioSig Technologies, Inc. He is an experienced executive and a seasoned industry veteran. He has over 30 years of business experience and has been Chief Executive Officer of several companies, both public and privately held, as well as run global business units of larger companies. Prior to joining BioSig, Mr. Cash was President and CEO of Argent International, a life sciences consulting firm. Previous positions include President and Chief Executive Officer of NeuroTherm, Inc.; President and Chief Executive Officer as well as a director of HeartSine Technologies, Inc.; President, Vascular Therapy and New Businesses for Sorin Group based in Milan, Italy; President and Chief Executive Officer and a director of Vasomedical, Inc., a Nasdaq-traded public company; Corporate Vice President, Datascope Corporation, and President of its subsidiary, InterVascular, Inc.; President and Chief Operating Officer of Eminent Technology Partners, and Chief Executive Office of its subsidiary, Eminent Research Systems; Vice President and General Manager, Vascular Therapies for U.S. Surgical Corporation; and spent five years with Boston Scientific Corporation, ultimately as Vice President, Cardiology Sales and Marketing, Europe. He began his career at Medtronic, Inc., where he served 14 years in increasingly senior sales and marketing positions. Mr. Cash has lived and worked as an expatriate in London, England; Hong Kong; Paris, France; and Milan, Italy, and speaks French, German and Italian. He holds a B.A. in international marketing and business administration from the College of St. Thomas in St. Paul, Minnesota. Profile
TWST: Can you begin by providing an overview of the company?

Mr. Cash: BioSig Technologies is a medical device company that has developed a proprietary technology platform designed to

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy